230 related articles for article (PubMed ID: 10356577)
1. [HIV infections: mortality reduced only in developed countries].
Wehr A
Dtsch Med Wochenschr; 1999 May; 124(18):A8-9. PubMed ID: 10356577
[No Abstract] [Full Text] [Related]
2. What's new and what's next.
Fakuda D
Posit Dir News; 1998 Jan; 10(1):25-9. PubMed ID: 11365053
[TBL] [Abstract][Full Text] [Related]
3. Four new antiretroviral medications will soon offer more options to HIV patients.
Murphy MJ
Fac Notes (New Orleans La); 1998; 10(4):1-3. PubMed ID: 11365545
[TBL] [Abstract][Full Text] [Related]
4. [HIV infection: DuPont Pharma presents the results of its antiretroviral agent].
Allerg Immunol (Paris); 1998 Apr; 30(4):123-4. PubMed ID: 9631694
[No Abstract] [Full Text] [Related]
5. Efficacy and safety of abacavir plus efavirenz as a salvage regimen in HIV-infected individuals after 48 weeks.
Wasmuth JC; Herhaus C; Römer K; Salzberger B; Kaiser R; Schliefer K; Voigt E; Rockstroh JK
AIDS; 2002 May; 16(7):1077-8. PubMed ID: 11953478
[No Abstract] [Full Text] [Related]
6. Switching from protease inhibitors to the non-nuke efavirenz.
TreatmentUpdate; 2001; 12(12):3. PubMed ID: 11570089
[No Abstract] [Full Text] [Related]
7. Don't mix Sustiva with Fortovase.
Posit Aware; 1998; 9(5):17. PubMed ID: 11365885
[TBL] [Abstract][Full Text] [Related]
8. Intravenous drug users risk group should also benefit from simpler highly active antiretroviral therapy.
Parienti JJ
AIDS; 2002 Oct; 16(15):2097; author reply 2098. PubMed ID: 12370515
[No Abstract] [Full Text] [Related]
9. Antiretroviral therapy for previously treated patients.
Montaner JS; Mellors JW
N Engl J Med; 2001 Aug; 345(6):452-5. PubMed ID: 11496858
[No Abstract] [Full Text] [Related]
10. Novel approaches for the treatment of HIV.
Arroyo HT
Newsline People AIDS Coalit N Y; 1998 Mar; ():16-7. PubMed ID: 11367450
[TBL] [Abstract][Full Text] [Related]
11. Protease inhibitor failure trial: combination 1592, 141W94, and efavirenz.
AIDS Treat News; 1997 Dec; (No 284):4. PubMed ID: 11364914
[TBL] [Abstract][Full Text] [Related]
12. New expanded access drugs for use in combination therapy.
Notes Undergr; 1998; (No 37):suppl 1-2. PubMed ID: 11365823
[TBL] [Abstract][Full Text] [Related]
13. Drifting agenda for federal treatment research.
Huff B
GMHC Treat Issues; 2001 May; 15(5):1-4. PubMed ID: 11548299
[No Abstract] [Full Text] [Related]
14. Antiretroviral therapy in the experienced patient.
Gallant JE
Hopkins HIV Rep; 1999 Mar; 11(2):1, 4, 9, 16. PubMed ID: 11366245
[TBL] [Abstract][Full Text] [Related]
15. DMP 266 and indinavir combination.
AIDS Patient Care STDS; 1997 Aug; 11(4):287-8. PubMed ID: 11361845
[No Abstract] [Full Text] [Related]
16. Treatment of the naive patient.
Bartlett JG
Hopkins HIV Rep; 1999 Mar; 11(2):1, 10-1. PubMed ID: 11366244
[TBL] [Abstract][Full Text] [Related]
17. Four-drug regimens may be better.
AIDS Patient Care STDS; 2000 Dec; 14(12):671. PubMed ID: 11119435
[No Abstract] [Full Text] [Related]
18. Drugs of tomorrow.
Posit Aware; 1998; 9(3):27-31. PubMed ID: 11365484
[TBL] [Abstract][Full Text] [Related]
19. Combination study for children.
Vazquez E
Posit Aware; 1998; 9(1):15. PubMed ID: 11364991
[TBL] [Abstract][Full Text] [Related]
20. Clinical update: new drugs for HIV/AIDS.
Gracia Jones S; Baggett TH
Medsurg Nurs; 1999 Apr; 8(2):108-12. PubMed ID: 10410008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]